Skip to Content

PRIMECAP Odyssey Aggressive Growth POAGX

Medalist Rating as of | See PRIMECAP Investment Hub
  • NAV / 1-Day Return 41.57  /  −1.26 %
  • Total Assets 6.7 Bil
  • Adj. Expense Ratio
    0.660%
  • Expense Ratio 0.660%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.02%
  • Turnover 5%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis POAGX

Will POAGX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Rekindling past success.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

With its outstanding investment team and high-conviction multimanager approach, Primecap Odyssey Aggressive Growth is exemplary within the mid-growth Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings POAGX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Dreyfus Treasury Secs Cash Mgmt Inst

5.04 362.5 Mil
Corporate

Eli Lilly and Co

4.90 351.8 Mil
Healthcare

Splunk Inc

3.61 259.5 Mil
Technology

Micron Technology Inc

3.51 252.1 Mil
Technology

Rhythm Pharmaceuticals Inc

3.30 237.5 Mil
Healthcare

Biogen Inc

3.16 227.0 Mil
Healthcare

Sony Group Corp ADR

2.78 199.9 Mil
Technology

Biomarin Pharmaceutical Inc

2.60 186.7 Mil
Healthcare

Tesla Inc

2.48 178.6 Mil
Consumer Cyclical

Flex Ltd

2.47 177.2 Mil
Technology